Last week, I attended the annual investment day, BioDisrupt, at the Amyris ( AMRS ) headquarters in Emeryville. Unless otherwise cited, all of the numbers below are taken from the talks at the event, which can be viewed here . There were some good news, some bad news, and some inconsequential…